A detailed history of Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) holds 74,269 shares of BMRN stock, worth $4.98 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
74,269
Holding current value
$4.98 Million
% of portfolio
0.07%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$74.43 - $92.22 $5.53 Million - $6.85 Million
74,269 New
74,269 $6.12 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.5B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) Portfolio

Follow Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden (The Fourth Swedish National Pensionfund), based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) with notifications on news.